Kennebec Savings Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8K Hold
892
0.03% 169
2026
Q1
$32.8K Hold
892
0.03% 163
2025
Q4
$45.4K Hold
892
0.04% 148
2025
Q3
$49.5K Hold
892
0.05% 138
2025
Q2
$61.6K Hold
892
0.06% 128
2025
Q1
$61.9K Hold
892
0.07% 128
2024
Q4
$75.5K Hold
892
0.08% 123
2024
Q3
$106K Buy
+892
New +$119K 0.11% 110

Other funds holding NVO

Kennebec Savings Bank's NVO Position: Q2 2026 in Review

Kennebec Savings Bank held its Novo Nordisk (NVO) position steady in Q2 2026 at 892 shares worth $42.8K. The position accounts for 0.03% of the portfolio, ranked #169.

Kennebec Savings Bank first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $106K in Q3 2024. 452 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Kennebec Savings Bank held 892 shares of Novo Nordisk worth $42.8K as of Q2 2026.
  • Kennebec Savings Bank left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.03% of Kennebec Savings Bank's portfolio in Q2 2026, its #169 holding.
  • Kennebec Savings Bank first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
  • Kennebec Savings Bank's Novo Nordisk position peaked at $106K in Q3 2024.
  • 452 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.